ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00977574
Brief Title: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

First Submitted : September 12, 2009
First Submitted that Met QC Criteria : September 12, 2009
First Posted : September 15, 2009 (Estimate)

Results First Submitted : October 20, 2017
Results First Submitted that Met QC Criteria : January 29, 2018
Results First Posted : February 27, 2018

Last Update Submitted that Met QC Criteria : January 29, 2018
Last Update Posted : February 27, 2018